Physical Activity Reduces Biological Aging Markers in Cancer Survivors
A study of breast cancer survivors found that those who engaged in a structured exercise program demonstrated slower epigenetic aging over 12 months compared to a control group receiving only health education. The findings suggest exercise may counteract the accelerated aging process that occurs in cancer survivors due to elevated senescent cells from chemotherapy and radiation treatments. This research provides evidence that physical activity helps maintain cellular health and cognitive function in this population.
Cancer treatments like chemotherapy and radiation therapy leave survivors with higher numbers of senescent cells—dysfunctional cells that accumulate in tissues and trigger chronic inflammation. This cellular burden contributes to premature aging in survivors, manifesting as reduced life expectancy and increased vulnerability to secondary cancers. The mechanism appears connected to how well the body can activate autophagy, its natural cellular cleanup process.
The research compared two groups of breast cancer survivors over a year: those following a structured exercise regimen and those receiving health education alone. Using epigenetic clocks to measure biological aging at multiple timepoints, researchers found exercise participants showed slower aging progression. Notably, improvements in epigenetic markers correlated with better cognitive performance, suggesting physical activity's benefits extend beyond tissue repair to brain function preservation.
This finding could reshape post-cancer care protocols by elevating exercise from general wellness advice to evidence-based intervention against accelerated aging. For the millions of cancer survivors managing long-term health concerns, accessible exercise programs might reduce risks of cognitive decline and secondary conditions. Healthcare systems may need to invest in structured, remotely delivered fitness programs as standard survivorship care. However, determining exercise's effectiveness relative to other senescence-targeting interventions remains ongoing research requiring larger, longer-term studies.